Siga Technologies Inc (SIGA): EPS (Diluted)
$0.32
Year ended 2025-12-31
-11.4%
3-year compound annual growth
-14.7%
5-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.32 | -61.0% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $0.82 | -13.7% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $0.95 | +106.5% | 2026-03-10, From 2023-01-01 |
| 2022-12-31 | $0.46 | -49.5% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $0.91 | +28.2% | 2024-03-12, From 2021-01-01 |
| 2020-12-31 | $0.71 | n/m | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | -$0.15 | n/m | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | $5.18 | n/m | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | -$0.46 | n/m | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | -$0.69 | n/m | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | -$0.73 | n/m | 2016-03-04, From 2015-01-01 |
| 2014-12-31 | -$4.97 | n/m | 2016-03-04, From 2014-01-01 |
| 2013-12-31 | -$0.33 | n/m | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | -$0.27 | n/m | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $0.09 | n/m | 2014-03-10, From 2011-01-01 |
| 2010-12-31 | -$1.12 | n/c | 2013-05-15, From 2010-01-01 |
| 2009-12-31 | -$0.52 | n/a | 2012-03-01, From 2009-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Siga Technologies Inc (SIGA) | 2025-12-31 | $0.32 | -61.0% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$6.54 | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | -$0.20 | n/m |
| Zymeworks Inc. (ZYME) | 2025-12-31 | -$1.08 | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$1.74 | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $1.35 | n/m |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | -$3.05 | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $2.06 | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$2.40 | n/m |
Compare SIGA, CYTK, LAB, ZYME side by side · Screen every company in Pharmaceutical Preparations ↗